Thermo-Transient Receptor Potential Channels: Therapeutic Potential in Gastric Cancer

Gang-Fan Zong1, Rui Deng1, Su-Yun Yu1,2

  • 1Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China.

Insights

Transient Receptor Potential (TRP) channels, especially thermally sensitive TRP channels, are linked to gastric cancer (GC) development. Understanding these thermo-TRP channels offers new diagnostic and therapeutic strategies for GC.

Area of Science:

  • Molecular Biology
  • Oncology
  • Physiology

Background:

  • Transient Receptor Potential (TRP) channels are increasingly recognized for their roles in cellular functions.
  • Abnormal expression of TRP channels, particularly the thermally sensitive subclass (thermo-TRPs), is implicated in various diseases.
  • Thermo-TRP channels play a significant role in the occurrence and progression of gastric cancer (GC).

Purpose of the Study:

  • To review and summarize current literature on thermo-TRP protein expression changes in gastric cancer.
  • To discuss the pathological and physiological implications of thermo-TRP involvement in GC.
  • To identify potential thermo-TRP targets for GC diagnosis and treatment.

Main Methods:

  • Literature review of existing studies on thermo-TRP channels and gastric cancer.
  • Analysis of research linking thermo-TRP expression to GC incidence and progression.
  • Synthesis of information on the role of thermo-TRPs in GC pathology and cell physiology.

Main Results:

  • Abnormal expression patterns of specific thermo-TRP channels are associated with gastric cancer.
  • Thermo-TRP channels are involved in key cellular processes relevant to GC development and progression.
  • These channels represent promising targets for novel GC diagnostic and therapeutic interventions.

Conclusions:

  • Thermo-TRP channels are critically involved in gastric cancer pathogenesis.
  • Targeting thermo-TRP proteins may offer new avenues for managing GC.
  • Further research into thermo-TRP mechanisms is essential for advancing GC treatment.

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
242
Thermosensation01:43

Thermosensation

Peripheral thermosensation is the perception of external temperature. A change in temperature (on the surface of the skin and other tissues) is detected by a family of temperature-sensitive ion channels called Transient Receptor Potential, or TRP, receptors. These receptors are located on free nerve endings. Those detecting cold temperatures are closer to the surface of the skin than the nerve endings detecting warmth. These thermoTRP channels, while temperature selective, have relatively...
31.0K
Mechanically-gated Ion Channels01:12

Mechanically-gated Ion Channels

Mechanically-gated ion channels are proteins found in eukaryotic and prokaryotic cell membranes that open in response to mechanical stress. Tension, compression, swelling, and shear stress can alter the conformation of the protein, opening a transmembrane channel that allows the passage of ions for signal transmission. In eukaryotes, mechanically-gated channels are distributed in several regions like the neurons, lungs, skin, bladder, and heart, where they play critical roles in numerous...
6.5K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
293
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.4K